Search
METiS Pharmaceuticals Clears HKEX Review: The 'SpaceX of the Pharmaceutical World' Poised to Become the 'First AI-Driven Nanodelivery Unicorn'
10 hour ago /
Read about 0 minute
Author：小编
METiS Pharmaceuticals is on the verge of making history as the "world's first AI-driven nanodelivery unicorn," distinguishing itself as the quickest among China's "three AI-powered drug discovery trailblazers" to reach the IPO stage. Established in 2020, this innovative firm specializes in the delivery and utilization of therapeutic agents within living organisms. Its cutting-edge solutions have not only expedited the creation of advanced treatments for a range of diseases but have also spurred the development of groundbreaking chemical formulations and delivery systems tailored to multiple key organs and tissues.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
